Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data.

Joshua M BaumlRavi VinnakotaYeun-Hee Anna ParkSusan E BatesTito FojoCharu AggarwalJessica Di StefanoChristina KnepleySewanti LimayeRonac MamtaniJuan WisniveskyNevena DamjanovCorey J LangerRoger B CohenKeith M Sigel

Published in: Cancer (2018)

Cetuximab with RT yields inferior OS in comparison with cisplatin for the nonoperative management of stage III to IVb HNSCC. According to this study, cisplatin may be the most appropriate partner for RT in this setting.

Keyphrases

locally advanced
rectal cancer
squamous cell carcinoma
radiation therapy
healthcare
public health
mental health
early stage
health information
social media
machine learning
artificial intelligence
hiv testing
hiv infected